Skip to content

Home
Our Story
Science
Programs
Platform
News

Home
Our Story
Science
Programs
Platform
News

Collaborate With Us

06/11/2024

New et al 2024 GLP-1 receptor agonists for treatment of diabetes and obesity – advantage of oral delivery

STAY UP TO DATE

Get our latest insights and project announcements

DIABETOLOGY

Oral Capsule Technology for Insulin, GLP-1 and Other Protein-Based Therapies and Combinations.

HEADQUARTERS:
Charter Place,
23/27 Seaton place,
St Helier,
Jersey JE1 1JY,
Channel Islands

The London BioScience Innovation Centre
2 Royal College Street, London, NW1 0NH
United Kingdom

Quick Links

Our Story
Science
Programs
Platform
Obesity Crisis
Diabetes Epidemic
Corporate Social Responsibility

Our Story
Science
Programs
Platform
Obesity Crisis
Diabetes Epidemic
Corporate Social Responsibility

Stay in Touch

Linkedin

Linkedin

Copyright © 2026 Diabetology Ltd. All rights reserved.

Privacy Policy
Terms of Use
Disclaimer

Privacy Policy
Terms of Use
Disclaimer

Subscribe to our newsletter

Name

Company

Email Address